Recent Updates
Recently added Catalysts
ICLR Positive Sentiment Score: 70/100

ICON plc to Present at the Baird Global Healthcare Conference DUBLIN--(BUSINESS WIRE)

Key Takeaway: ICON plc announced that CEO Dr. Steve Cutler will present at the Baird Global Healthcare Conference on September 13, 2023. The company, a top clinical research organization, provides services in drug development and healthcare intelligence. ICON has a strong workforce of approximately 41,160 employees distributed across 108 locations in 53 countries. However, the company cautions investors that its forward-looking statements are subject to risks and uncertainties that could affect future performance.

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Steve Cutler, CEO of ICON plc, will present at a notable healthcare conference.
  • ICON plc is recognized as a leading clinical research organization.
  • The company has a significant global presence with over 41,000 employees in multiple countries.

CONCERNS & RISKS

  • Forward-looking statements may not guarantee actual future performance.
  • The company faces uncertainties related to new contracts, market conditions, and integration of mergers.

Full Press Release Details

ICON plc to Present at the Baird Global Healthcare Conference

DUBLIN--(BUSINESS WIRE)--September 6, 2023--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Baird Global
Healthcare Conference on Wednesday, September 13, 2023 at 10:15 am ET.
Any changes to this event and links to the live webcasts (where available) will be posted on the Investor section of our website under "Events".
ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and
public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,160 employees in 108 locations in 53 countries as at June
30, 2023. For further information about ICON, visit: www.iconplc.com.
This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not
guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties
and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new
offices and offering of new services, the integration of new business mergers and acquisitions, the impact of COVID-19 on our business, as well as other economic and global market conditions and other risks and uncertainties detailed from time
to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions.
The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update
publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by
ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.

Contacts

Kate Haven, Vice President Investor Relations, +1888 381 7923

Frequently Asked Questions

When is ICON plc presenting at the Baird Conference?

ICON plc will present on September 13, 2023, at 10:15 am ET.

Who is representing ICON plc at the conference?

Dr. Steve Cutler, CEO of ICON plc, will represent the company.

Where can I find updates about the event?

Updates will be posted in the Investor section of ICON's website.

What does ICON plc specialize in?

ICON plc provides clinical research and healthcare intelligence services.

How many employees does ICON plc have?

As of June 30, 2023, ICON employed approximately 41,160 people.

Last updated: Sep 6, 2023